Europe Electrocardiograph (ECG) Market Outlook, 2028

In Europe Cardiologists use an electrocardiogram (ECG) to assess whether the electrical activity is fast, irregular, or normal. In order to determine whether the heart's components are overly big or overworked, it is also used to monitor the amount of electrical activity that flows through the heart muscle. An electrocardiogram (ECG) is a non-invasive medical test that records the heartbeat's electrical activity over time. An electrical impulse is produced by each heartbeat and is captured using electrodes. The electrodes pick up even the tiniest electrical fluctuations in the skin that result from the heart muscle depolarizing with each beating. According to the World Health Organisation, cardiovascular diseases account for the majority of deaths in Europe (WHO). Furthermore, the introduction of cutting-edge ECG gadgets including portable FCG devices and ECG gadgets connected to AI systems is anticipated to fuel market expansion.

The launch of new monitoring devices and advancements in the production of FCG equipment are two of the reasons propelling the market forward. Increased healthcare spending combined with rising individual disposable income is another factor driving the growth of the European ECG market. Both young and old people are experiencing a rise in cardiovascular disease as a result of changing lifestyle factors like food choices and an inactive lifestyle. The increased prevalence of cardiovascular disease (CVD) in Europe has led to a significant demand for medical devices, including electrodes for electrocardiograms.

The ECG electrode market is growing as a result of healthcare practitioners and institutions actively searching for advanced technologies to provide precise cardiac monitoring due to the rising prevalence of heart-related illnesses in the region. According to the European Society of Cardiology, about 11 million new cases of CVD are recorded each year, accounting for 45% of all fatalities in the region. Furthermore, the annual economic cost of CVD in the region surpasses USD 220 billion. The market is growing as a result.

According to the research report"Europe Electrocardiograph (ECG) Market Outlook, 2028,", the Europe Electrocardiograph (ECG) market is anticipated to add USD 800 Million from 2023 to 2028. The integration of AI in ECG devices for more accurate and efficient analysis has been a growing trend. AI algorithms can assist in the early detection of abnormalities and provide healthcare professionals with valuable insights. Continuous technological advancements have been a significant trend in the ECG market. This includes the development of portable and wireless ECG devices, making it more convenient for patients to monitor their heart health remotely. There is a shift towards preventive healthcare, and ECG devices play a crucial role in identifying potential heart issues before they become more severe. This preventive approach aligns with broader efforts to reduce healthcare costs and improve patient outcomes.

The integration of ECG data into digital health platforms and electronic health records (EHRs) has been a trend. This enables seamless sharing of patient information among healthcare providers and facilitates better continuity of care. The proliferation of mobile health applications that integrate with ECG devices has been on the rise. These apps not only facilitate ECG monitoring but also provide users with actionable insights, health recommendations, and the ability to share data with healthcare providers. Economic considerations, such as cost-effectiveness and efficiency in healthcare delivery, play a role in shaping market trends.

Healthcare providers and systems are increasingly looking for solutions that offer value for money while maintaining high-quality patient care. Regulatory frameworks surrounding telemedicine and remote patient monitoring impact the adoption of ECG devices. Changes in regulations and reimbursement policies can influence how healthcare providers incorporate ECG technologies into their service offerings.

The market is spilt-up into Germany, United Kingdom, France, Italy, Spain and Russia. Germany is the largest economy in Europe and one of the leading economies globally. The country's economic strength contributes to robust healthcare infrastructure and high levels of healthcare spending, fostering a favorable environment for the adoption of advanced medical technologies, including ECG devices. Germany boasts a well-developed and advanced healthcare infrastructure with a strong emphasis on technological innovation. The country's healthcare system is characterized by a high standard of care, and this commitment to excellence extends to the adoption of cutting-edge medical technologies. German companies are often at the forefront of research and development in the medical technology sector. The country has a history of investing in innovation, and this commitment to R&D enables the development of state-of-the-art ECG devices with advanced features and capabilities.

The prevalence of cardiovascular diseases is a significant health concern in Germany, as in many developed countries. The need for accurate and advanced diagnostic tools for cardiovascular conditions, such as ECG devices, drives demand in the market. Furthermore, If Spain experiences an increase in healthcare expenditure; it could lead to greater investment in advanced medical technologies, including ECG devices. A rise in funding for healthcare infrastructure and services may contribute to market growth. Ageing populations often lead to a higher incidence of cardiovascular diseases. If Spain experiences demographic shifts with an ageing population, there could be a corresponding increase in the demand for cardiovascular diagnostic tools, including ECG devices.

Based on Product the market is segmented into Resting Electrocardiograph (ECG), Stress Electrocardiograph (ECG), Holter Monitors, Event Recorders and Others. Among them Resting Electrocardiograph (ECG) is expected to leading the Europe Electrocardiograph (ECG) market. Resting ECGs are commonly used for routine diagnostics during standard medical check-ups and examinations. These tests are part of regular health assessments, making resting ECGs a fundamental tool in primary care and outpatient settings. Resting ECGs play a crucial role in screening for cardiovascular diseases, such as coronary artery disease and arrhythmias. Given the high prevalence of cardiovascular conditions in Europe, there is a consistent demand for diagnostic tools that can efficiently detect abnormalities during rest. Resting ECGs are non-invasive and relatively easy to administer.

The simplicity of the procedure makes it suitable for a wide range of patients, from children to the elderly, contributing to its popularity and widespread use in clinical practice. Resting ECGs are generally considered cost-effective compared to more complex diagnostic procedures. As a result, they are often preferred in initial assessments and routine screenings, making them a cost-efficient option for healthcare providers. Resting ECGs are commonly included in routine health check-ups and wellness programs. The emphasis on preventive healthcare has increased the demand for regular cardiovascular screenings, further supporting the use of resting ECGs.

Europe has an aging population, and older individuals often require regular cardiovascular monitoring. Resting ECGs are well-suited for this demographic, as they provide valuable insights into the heart's health during periods of rest, helping in the management of age-related cardiovascular conditions.

In terms of end user the market is bifurcated into Hospitals & Clinics, Home Settings & Ambulatory Surgical Centers (ASCs) and others. Home-based ECG monitoring is particularly beneficial for individuals managing chronic cardiovascular conditions. Regular ECG tests at home can aid in the early detection of abnormalities, facilitate timely interventions, and improve overall disease management. Advances in technology, including the development of compact and wireless ECG devices, have made it feasible to bring diagnostic capabilities into home settings. These devices are often designed for ease of use, allowing patients to perform self-monitoring with minimal effort.

Home ECG devices are designed to be user-friendly, requiring minimal training for patients to use them effectively. The simplicity of operation encourages regular usage, facilitating continuous monitoring and early detection of potential cardiac issues. ASCs often offer specialized diagnostic services, including ECG testing.

This specialization allows these centers to focus on providing high-quality cardiovascular diagnostics and care, attracting patients seeking expertise in outpatient settings. ASCs often prioritize same-day procedures and tests, minimizing the need for overnight hospital stay. Resting ECGs, being a quick and non-invasive procedure, align with the trend of providing timely diagnostic results within a single outpatient visit. The number of Ambulatory Surgical Centers in Europe has been on the rise. As the availability and accessibility of ASCs increase, so does the potential for more individuals to undergo ECG tests in these centers, driving market growth.

Recent Developments:

• In January 2022, Philips introduced a new at-home, 12-lead ECG solution for decentralized clinical trials. This solution is designed to improve compliance, patient recruitment and retention by reducing the need for site visits.
• In June 2022, AliveCor released the KardiaMobile Card, a credit-card-sized ECG device that provides a medical-grade ECG in 30 seconds. It is the world's first FDA-cleared credit-card-sized ECG device.
• In March 2021, Rhythmlink received FDA clearance for its new Sticky Pad Surface Electrodes, used for Intraoperative Neurophysiological Monitoring (IONM) and Electroencephalography (EEG) in 1.5 and 3 Tesla MRI environments.
• In September 2021, Bittium's launched new OmegaSnap patch electrodes offer 1-CH, 2-CH, and 3-CH ECG measurements compatible with the Bittium Faros ECG device

Companies Covered in this report:

Koninklijke Philips N.V., GE HealthCare Technologies, Inc., Midmark Corporation, Schiller AG, Nihon Kohden Corporation, Baxter International Inc., Medline Industries, EDAN Instruments, Inc., Bionet Co., Ltd., Fukuda Denshi Co Ltd, OSI Systems, Inc., Mindray Medical International Limited.

Considered in this report

• Geography: North America
• Historic year: 2017
• Base year: 2022
• Estimated year: 2023
• Forecast year: 2028

Aspects covered in this report

• North America Electrocardiograph (ECG) market Outlook with its value and forecast along with its segments
• Country-wise Electrocardiograph (ECG) market analysis
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

Country covered in the report:

• Germany
• United Kingdom
• France
• Italy
• Spain
• Russia

By Product

• Resting Electrocardiograph (ECG)
• Stress Electrocardiograph (ECG)
• Holter Monitors
• Event Recorders
• Others

By End User

• Hospitals & Clinics
• Home Settings & Ambulatory Surgical Centers (ASCs)
• Others

The approach of the report:

This report consists of a combined approach of primary and secondary research. Initially, secondary research was used to get an understanding of the market and list the companies that are present in it. The secondary research consists of third-party sources such as press releases, annual reports of companies, and government-generated reports and databases. After gathering the data from secondary sources, primary research was conducted by conducting telephone interviews with the leading players about how the market is functioning and then conducting trade calls with dealers and distributors of the market. Post this; we have started making primary calls to consumers by equally segmenting them in regional aspects, tier aspects, age group, and gender. Once we have primary data with us, we can start verifying the details obtained from secondary sources.

Intended audience

This report can be useful to industry consultants, manufacturers, suppliers, associations, and organisations related to the Electrocardiograph (ECG) industry, government bodies, and other stakeholders to align their market-centric strategies. In addition to marketing and presentations, it will also increase competitive knowledge about the industry.


This product will be delivered within 2 business days.